# BlackRock Income and Growth Investment Trust NAV returned 27.1% for the half-year

- Link: https://www.directorstalkinterviews.com/blackrock-income-and-growth-investment-trust-nav-returned-27.1-for-the-half-year/4121003937
- Published: 2021-06-24T08:08:04+01:00
- Author: Amilia Stone

**BlackRock Income and Growth Investment Trust plc** ([LON:BRIG](https://www.directorstalkinterviews.com/company/blackrock-income-and-growth-investment-trust-plc/brig.l))
has announced its half-yearly financial report for the six months ended 30 April
2021.

**For more information on the BlackRock Income and Growth Investment Trust and how
to access the opportunities presented by the income and growth sector, please visit:
[www.blackrock.com/uk/brig](https://www.blackrock.com/uk/individual/products/investment-trusts/our-range/blackrock-income-and-growth-investment-trust/trust-information?siteEntryPassthrough=true&cid=aff:investmenttrusts2020:brig:directorstalk:link)**

**PERFORMANCE RECORD**

| 
  | As at 30 April 2021  | As at 31 October 2020  | Change %  | 
| Net assets (£’000)^(1) | 43,924  | 36,401  | 20.7  | 
| Net asset value per ordinary share (pence) | 200.63  | 161.70  | 24.1  | 
| Ordinary share price (mid-market) (pence) | 184.00  | 162.50  | 13.2  | 
| (Discount)/premium to net asset value^(2) | (8.3)%  | 0.5%  |  | 
| FTSE All-Share Index | 7,754.43  | 6,036.60  | 28.5  | 
|  | ========  | ========  | ========  | 
| **Performance (with dividends reinvested)** |  |  |  | 
| Net asset value per share^(2) | 27.1%  | -16.7%  |  | 
| Ordinary share price^(2) | 16.2%  | -14.8%  |  | 
| FTSE All-Share Index | 28.5%  | -18.6%  |  | 
|  | ========  | ========  |  |

| 
  | For the six months ended 30 April 2021  | For the six months ended 30 April 2020  | Change %  | 
| **Revenue** |  |  |  | 
| Net profit after taxation (£’000) | 699  | 699  | –  | 
| Revenue earnings per ordinary share (pence)^(3) | 3.15  | 3.06  | 2.9  | 
| **Dividends (pence)** |  |  |  | 
| Interim | 2.60  | 2.60  | –   | 
|  | ========  | ========  | ========  |

^(1)               The change in net assets reflects the market movements during
the period, the purchase of the Company’s own shares and dividends paid.
^(2)   
Alternative Performance Measures, see Glossary in the Half Yearly Financial Report.
^(3)               Further details are given in the Glossary in the Half Yearly 
Financial Report.

**CHAIRMAN’S STATEMENT**

Dear Shareholder

**OVERVIEW**
Once again, it is necessary to begin my report to our shareholders 
with a reference to the continuing effects of the COVID-19 pandemic in creating 
economic upheaval and volatility in financial markets. The several new variants 
of the COVID-19 virus which have been detected in the UK in recent months have contributed
to uncertainty about the pace of reopening of our economy whilst recent months have
also witnessed an upturn in inflation as prices of fuel, energy and commodities 
have all risen. The UK’s exit from the EU and the operation of the trade and services
agreement now in force have yet to see early teething problems ironed out, and amongst
the other effects of the pandemic there are signs that certain supply chains may
have been temporarily or even permanently altered with potentially far-reaching 
consequences. Many companies are responding to this disruption and improving resilience
in their supply chains through collaboration and technology.

That said, there are also reasons for optimism as an investor in the UK. As COVID-
19 restrictions have eased, we have seen a surge in activity across many sectors
and industries. The latest data on economic activity, productivity and employment
are promising and consumer confidence is returning, demonstrated by a spike in retail
spending which has risen sharply in recent months, providing a much-needed boost
to the UK economy. Fiscal and monetary policy remain supportive and the Bank of 
England has forecast that growth for 2021 will exceed 7%. This would represent the
strongest expansion in over 70 years, albeit partly based on lockdown restrictions
being lifted and remaining so. As we move into a more stable and benign environment,
and in light of what has been a very successful vaccination programme, in the UK
at least, the near-term outlook appears to be bright. Against this backdrop your
portfolio managers remain optimistic and believe our portfolio is well-positioned
to benefit from the many opportunities available as the economy returns to growth.

**PERFORMANCE**
During the period, the Company’s net asset value per share (NAV)
returned 27.1%, compared with the Company’s benchmark, the FTSE All-Share Index (
Total Return), which returned 28.5%. The Company’s share price returned 16.2% (all
percentages are in Sterling with dividends reinvested).

Subsequent to the period end and as at 22 June 2021, the net asset value per share
of the Company has increased by 1.7% from 200.63 pence per share to 204.05 pence
per share and the Company’s share price has risen by 6.0% from 184.00 pence to 195.00
pence per share. The Company’s Benchmark Index has increased by 1.5% over the same
period.

Further information on the significant components of overall performance and the
changes to portfolio composition are set out in the Investment Manager’s Report 
below.

**REVENUE PROFIT AND DIVIDENDS**
Revenue profit for the period was 3.15 pence per
share (six months to 30 April 2020: 3.06 pence per share). The Board is pleased 
to declare an interim dividend of 2.60 pence per share (2020: 2.60 pence per share).
This dividend will be paid on 1 September 2021 to shareholders on the Company’s 
register at the close of business on 23 July 2021 (the ex-dividend date is 22 July
2021).

As an investment trust, we have been able in years past to accumulate a measure 
of revenue reserves which can then be used to support the Company’s dividend distributions
in years when the underlying revenue from the portfolio is under pressure, as it
is currently. Your Company has one of the largest revenue reserves as a percentage
of net assets in the UK Equity Income sector and the Board is mindful of the importance
of dividend income to shareholders so intends to use these reserves to support the
dividend this year should it be required. After the payment of this year’s interim
dividend, the Company will have approximately one year’s dividend cover in revenue
reserves. The Board will continue to keep under review how this reserve should be
used in future years.

**OPERATIONAL RESILIENCE**
As I reported in this year’s Annual Report, throughout
the COVID-19 outbreak the Board has been working closely with our Manager, BlackRock,
and the Company’s key suppliers to minimise the risk the virus poses to the health
and wellbeing of all those engaged in the management and administration of the Company.
I am pleased to report that the Company’s operations have continued not to be adversely
affected. As a Board, we have continued to meet regularly, via video conference,
and I am hopeful that we can all return to some form of normalcy in the near future.

**SHARE CAPITAL**
The Directors recognise the importance to investors that the Company’s
share price should not trade at a significant discount to NAV, and therefore, in
normal market conditions, may use the Company’s share buy back, sale of shares from
treasury and share issuance powers to seek to ensure that the share price does not
differ excessively from the underlying NAV. Buying back shares at a discount is 
accretive to NAV and can help narrow the discount to NAV at which the Company’s 
shares trade. It can also help to provide additional liquidity. During the period,
the Company’s shares traded at an average discount of 7.6% to cum income NAV per
share. At the close of business on 22 June 2021 the discount stood at 4.4%.

A total of 618,635 ordinary shares were bought back and cancelled during the period
at an average price of 174.10 pence and for a total consideration of £1,077,000.
No shares were issued or sold from treasury during the period under review. As at
22 June 2021, 31.7% of the Company’s issued ordinary share capital is held in treasury
and may be issued to satisfy any demand for the Company’s shares that may arise.

**GEARING**
The Company operates a flexible gearing policy which depends on prevailing
conditions and the outlook for the market. Gearing is subject to a maximum level
of 20% of net assets at the time of investment. The Company has been modestly geared
during the period under review and at 30 April 2021 the Company had net gearing 
of 8.4%. Gearing levels and sources of funding are reviewed regularly to ensure 
that the Company has access to the most competitive borrowing rates available to
it. The Company currently has a two-year unsecured Sterling revolving credit facility
of £4,000,000 with ING Bank (Luxembourg) S.A., which is fully drawn down and is 
scheduled to mature in October 2021.

**OUTLOOK**
At the time of writing the full extent of the economic and social impact
of the pandemic remains necessarily unclear. Equally, the longer-term impacts on
how we live our lives, how businesses and public services operate and how governments
will seek to regain equilibrium in their finances are very hard to predict.

As you will read in their report which follows below, your investment managers’ 
fundamental strategy has not changed. As active managers they are excited about 
the opportunities the economic recovery will bring, but also measured and cautious
regarding the near term given the uncertainty that remains. They continue to seek
out companies that can generate cash flow from strong business models and have favourable
industry characteristics or scope for management driven self-help. The focus remains
on bottom-up stock selection, assembling a portfolio of individual companies which,
taken as a whole, should prove capable of delivering attractive returns and supporting
dividend growth into the future.

Your Board remains fully supportive of this approach. Moreover, I am confident that
in BlackRock we have a Manager of deep capabilities for our portfolio managers to
draw upon as they seek to position the portfolio to deliver on the Company’s investment
objective over the longer term.

**GRAEME PROUDFOOT**
**Chairman**23 June 2021

INVESTMENT MANAGER’S REPORT

**PERFORMANCE**
For the six months since 31 October 2020, the Company’s NAV returned
27.1%, underperforming its benchmark, the FTSE All-Share Index, which returned 28.5%
over the same period.

**INVESTMENT APPROACH**
In assembling the Company’s portfolio, we adopt a concentrated
investment approach to ensure that our best ideas contribute significantly to returns.
We believe that it is the role of the portfolio overall to generate an attractive
and growing yield alongside capital growth rather than every individual company 
within the portfolio. This gives the Company increased flexibility to invest where
returns are most attractive. This approach results in a portfolio which differs 
substantially from the index and in any individual year the returns will vary, sometimes
significantly from those of the index. Over longer periods our objective is to achieve
returns greater than the index, but with lower volatility. The foundation of the
portfolio, approximately 70%, is in high free cash flow companies that can sustain
cash generation and pay a growing dividend whilst aiming to deliver a double-digit
total return. Additionally, we look to identify and invest 20% of the portfolio 
in ‘growth’ companies that have significant barriers to entry and scalable business
models that enable them to grow consistently. We also look for turnaround companies,
at around 10% of portfolio value, which represent those companies that are out of
favour with the market, facing temporary challenges with high yields or very low
valuations, but with attractive recovery potential.

**MARKET REVIEW**
The end to 2020 was marked by the turbulence that characterised
an extraordinary year. Politics were, as expected, a significant factor as Joe Biden
won the US Presidential Election after a sustained period of inconclusion and Brexit
negotiations provided a degree of uncertainty, however, the progress of the pandemic
and its ramifications were the major source of market movements. Investors were 
both buoyed by the strong clinical data from a number of vaccines and alarmed by
the impact of repeat waves of the virus and its mutation. The announcement on 9 
November 2020 of the data from the Pfizer/BioNTech vaccine showing greater than 
90% efficacy generated remarkable and rapid market moves; equity markets soared,
momentum reversed at a rate never previously seen and the value factor rallied strongly.

December finally delivered positive progress on Brexit, with an agreement on trade
terms for goods. Small and mid-cap indices outperformed the [FTSE 100](https://www.directorstalkinterviews.com/news/ftse-100)
in the fourth quarter as their domestic bias benefited from the progress in Brexit
negotiations. Positive news on Brexit was offset by an alarming increase in the 
incidence of the COVID-19 virus as several new variants proved particularly contagious.
This triggered a renewed lockdown in the UK, initially eased at the start of March
with reopening of schools, and further eased in April with the reopening of non-
essential retail.

Global stock markets made a strong start to 2021 as vaccination programmes and stimulus-
boosted optimism around the recovery trumped concerns around virus variants. Rising
bond yields undermined longer-duration sectors and a rebound in cyclical earnings
continued to drive a rally in value-related names. Reflation risks were placed under
the spotlight as commodity prices appreciated. Risk on sentiment swelled towards
the end of the period, further bolstered by a robust corporate earnings season, 
strong global economic data releases and increasing COVID-19 inoculation.

While the UK and US made a strong start to virus inoculation and continued strong
vaccine deployment throughout the period, Europe’s vaccine rollout had a slower 
start, however, but later significantly improved. At the end of the period, concerning
virus news came from India where the country grappled with soaring COVID-19 cases
and shortages of medical resources.

The FTSE All-Share benchmark rose 28.5% over the six months to 30 April 2021 with
Basic Materials, Oil & Gas and Telecommunications as top outperformers.

**CONTRIBUTORS AND DETRACTORS TO PERFORMANCE**
As the market rotation at the end
of 2020 continued into 2021, the six-month period to 30 April saw a shift into more
cyclical sectors and stocks as confidence grew around vaccine progress and increased
stimulus. Sectors including Housebuilders, Industrials, and Travel & Leisure were
beneficiaries of this shift and more defensive sectors including Consumer Staples
and Health Care lagged.

Housebuilder, **Taylor Wimpey**, was the top contributor to the portfolio during
the period. **Halifax** has reported average house prices are +8.2% year-on-year
in April. High demand levels, driven by a reassessment of space requirements post
lockdown and ongoing support from the stamp duty holiday are combining with a tight
supply environment. **Grafton** was another top contributor as strong performance
continued and the company lifted profit guidance. Another Industrial, **Electrocomponents**,
performed well as recovery in the company’s end markets and ongoing market share
gains powered accelerated growth. After facing unprecedented challenges on the back
of global lockdowns in early 2020, the Travel & Leisure sector rallied strongly 
after the announcement of effective COVID-19 vaccines. As a result, companies including
hotel group, **Whitbread** and airport and train station caterer, **SSP**, fared
well during the period after having been previously severely impacted by COVID-19.

As a quality business with a defensive earning stream, **Reckitt Benckiser** underperformed
and was the top detractor from the portfolio during the period; the market favoured
more cyclical companies despite Reckitt Benckiser delivering strong results at the
end of the period. Other defensive names such as **Rentokil** **Initial**, **Rightmove**
and **AstraZeneca** also detracted from the portfolio as shares lagged. One key 
stock-specific disappointment during the period was insurer, **Hiscox**, which issued
a poor trading statement that highlighted further investments needed within its 
retail business. Our underweight positioning to the Basic Materials sector and lack
of holding in **Glencore** and **Anglo American** also detracted from performance
given the strength in the sector during the period.

**TRANSACTIONS**
As the Company moved through the early part of the crisis in March
and April last year, the significant dislocation in the market provided opportunities
to buy new positions. Notably, the Company had its busiest four weeks on record 
adding a total of eight new positions following substantial falls in share prices.
With the confirmation of effective vaccines in November and continued fiscal and
monetary support, our optimism around a recovery grew and we began tilting the portfolio
more cyclically. We purchased **Hays**, **IntegraFin**, **Smiths** **Group** and
sold **National Grid**, **United Utilities**, and **Vodafone**.

Investment platform, **IntegraFin**, is a high-quality play on pensions freedoms
and people taking a more active approach to savings. **IntegraFin** provides infrastructure
for Independent Financial Advisors (IFAs) which we view as a unique offering compared
to other platforms. We purchased recruiting firm **Hays** as we feel it is well 
placed to benefit from reopening and increased employee mobility. **Smiths** **Group**
is a diversified engineering business consisting of a collection of four predominantly
industrial focused divisions and a medical devices division. The sale or demerger
of the medical devices division this year will leave the rest of the group trading
at an attractive valuation and at a significant discount to industrial peers despite
its collection of high-quality businesses where activity is improving in the end
markets.

We now have the ability to invest up to 20% of the Company in overseas holdings,
and we believe that investing overseas enhances the potential capital return and
income generation of the portfolio. Investing overseas broadens our universe of 
income generators and provides access to themes or industries not available in the
UK market, for example digital payments through exposure to **Mastercard**. During
the period we increased our overseas exposure to 10.8% (as at 30 April 2021); we
participated in the Initial Public Offering (IPO) of **Hemnet** which is the leading
residential property portal in Sweden and is well-placed to grow through developing
its product suite. We also purchased **AXA**; a leading composite insurer in Europe
where the investment case is a function of an improving backdrop for insurance rates,
an attractive absolute and relative valuation (including a 6% dividend yield), and
operational improvement as legacy issues are addressed.

We sold our holding in **Vodafone** after recent news flow around their towers business
underwhelmed and given the competition for capital elsewhere in the portfolio. We
also sold **National Grid** and **United Utilities** as we tilted the portfolio 
more cyclically and we exited **Fevertree** following its strong performance. We
also sold our position in **Rightmove** as we see better opportunities elsewhere.

During the period, we sought out idiosyncratic opportunities including participating
in the IPO of **Moonpig Group**, which is a beneficiary of the shift to online retail.
The company has built an enviable position in the UK greeting card market; it has
delivered exceptional growth in the pandemic which will normalise in coming months
but growth should resume in 2022, driven by increased frequency of purchase at higher
values following the development of the gifting range.

We remain constructive on economic growth and the tailwind to cyclical areas of 
the stock market while remaining cognisant of more defensive companies’ attractive
free cash flow generation.

**OUTLOOK**
Despite the continuation of COVID-19 lockdowns globally, economic activity
has been less impacted as consumers and corporates have adapted their behaviours
since the development of effective vaccines. Looking ahead, the focus is firmly 
on the cyclical recovery buoyed by ongoing monetary and fiscal support overwhelming
concerns around virus variants.

As economic activity rebounds this has caused some strains on supply chains with
specific industry shortages as well as building inflationary pressures including
significant increases in commodity prices versus twelve months ago. The prospect
of higher inflation has driven bond yields higher with central bankers appearing
to indicate willingness, for now, to refrain from any material rise in interest 
rates. We are also cognisant of the evolution of relationships between China and
the West and the potential impact on industries and shares.

Turning to the UK specifically, the recently published Bank of England report showed
continued momentum in UK Gross Domestic Product with expected growth the fastest
in post-war records as the UK recovers from an extremely weak COVID-19 impacted 
2020. This is against a backdrop of UK valuations that have been extreme, trading
at multi-decade lows versus other international markets with a recent flurry of 
merger and acquisition deals highlighting the dispersion and value on offer in the
FTSE. We continue to believe that this dispersion should narrow given the increased
certainty and reduced risk regarding Brexit in addition to the UK’s strong vaccination
effort.

We view the dividend outlook for the UK market with renewed optimism as we expect
dividends, in aggregate, to be more resilient and to grow faster in the future as
those companies that had been overdistributing for a number of years reset their
dividends during the pandemic. Resilience was a crucial feature of the Company and
its underlying holdings in 2020 and while this will still be important in 2021, 
we are excited by the approaching economic recovery and the opportunity to deliver
strong capital and dividend growth for our clients over the long-term.

**ADAM AVIGDORI AND DAVID GOLDMAN**
**BLACKROCK INVESTMENT MANAGEMENT (UK) LIMITED**
23 June 2021

TEN LARGEST INVESTMENTS

**1 =** **AstraZeneca** (2020: 1st)
**Sector: Pharmaceuticals & Biotechnology****
Market value: £2,927,000****Percentage of portfolio: 6.1% (2020: 7.1%)**

AstraZeneca is a multinational pharmaceutical group with its headquarters in the
UK. It is a science-led biopharmaceutical business with a portfolio of products 
for major disease areas including cancer, cardiovascular infection, neuroscience
and respiratory.

**2** + **Rio Tinto** (2020: 6th)
**Sector: Mining****Market value: £2,540,000****
Percentage of portfolio: 5.3% (2020: 3.9%)**

Rio Tinto is a metals and mining group operating in about 36 countries around the
world, producing iron ore, copper, diamonds, gold and uranium.

**3 =** **Reckitt Benckiser** (2020: 3rd)
**Sector: Household Goods & Home Construction****
Market value: £2,194,000****Percentage of portfolio: 4.6% (2020: 5.0%)**

Reckitt Benckiser is a global leader in consumer health, hygiene and home products.
Its products are sold in 200 countries and its 19 most profitable brands are responsible
for 70% of net revenues.

**4 –**** Unilever** (2020: 2nd)
**Sector: Food Producers****Market value: £1,963,000****
Percentage of portfolio: 4.1% (2020: 5.8%)**

Unilever is a global supplier of food, home and personal care products with more
than 400 brands focused on health and well-being.

**5 –** **RELX** (2020: 4th)
**Sector: Media****Market value: £1,899,000****Percentage
of portfolio: 4.0% (2020: 5.0%)**

RELX is a global provider of professional information solutions that includes publication
of scientific, medical, technical and legal journals. It also has the world’s leading
exhibitions, conference and events business.

**6** – **British American Tobacco** (2020: 5th)
**Sector: Tobacco****Market value:
£1,773,000****Percentage of portfolio: 3.7% (2020: 4.6%)**

British American Tobacco is one of the world’s leading tobacco groups, with more
than 200 brands in the portfolio selling in approximately 180 markets worldwide.

**7 +** **Royal Dutch Shell ‘B’** (2020: 9th)
**Sector: Oil & Gas Producers****Market
value: £1,710,000****Percentage of portfolio: 3.6% (2020: 2.9%)**

Royal Dutch Shell is a global oil and gas group. The group operates in both Upstream
and Downstream divisions. The Upstream division is engaged in searching for and 
recovering crude oil and natural gas, the liquefaction and transportation of gas.
The Downstream division is engaged in manufacturing, distribution and marketing 
activities for oil products and chemicals.

**8 +** **Smith & Nephew** (2020: 12th)
**Sector: Health Care Equipment & Services****
Market value: £1,607,000****Percentage of portfolio: 3.4% (2020: 2.8%)**

Smith & Nephew is a multinational medical equipment manufacturing group. It produces
advanced wound management products, arthroscopy products, trauma and clinical therapy
products and orthopaedic reconstruction products, selling its products into over
120 countries.

**9 +** **Standard Chartered** (2020: 14th)
**Sector: Banks****Market value: £1,412,000****
Percentage of portfolio: 3.0% (2020: 2.5%)**

Standard Chartered is a multinational banking and financial services group headquartered
in London. It operates a network of more than 1,200 branches and outlets across 
more than 70 countries; working across some of the world’s most dynamic markets 
including Asia, Africa and the Middle East.

**10 +** **Ferguson** (2020: 15th)
**Sector: Support Services****Market value: £
1,316,000****Percentage of portfolio: 2.8% (2020: 2.4%)**

Formerly called Wolseley, Ferguson has scale as the largest plumbing and heating
distributor in the world with market leading procurement, technology and supply 
chains. The group also has a strong investment grade balance sheet which allows 
for good financing terms.

All percentages reflect the value of the holding as a percentage of total investments
as at 30 April 2021.

Together, the ten largest investments represent 40.6% of total investments (ten 
largest investments as at 31 October 2020: 43.4%).

**DISTRIBUTION OF INVESTMENTS AS AT 30 APRIL 2021**

**Analysis of portfolio by sector**

|  |  | % of investments by market value | 
Benchmark | 
| 1 | Financial Services | 11.0 | 4.5 | 
| 2 | Support Services | 10.7 | 4.5 | 
| 3 | Household Goods & Home Construction | 8.1 | 1.8 | 
| 4 | Pharmaceuticals & Biotechnology | 8.0 | 7.7 | 
| 5 | Mining | 7.4 | 0.4 | 
| 6 | Oil & Gas Producers | 6.1 | 7.2 | 
| 7 | Banks | 5.1 | 7.8 | 
| 8 | Life Insurance | 4.6 | 3.3 | 
| 9 | Travel & Leisure | 4.5 | 3.9 | 
| 10 | Food Producers | 4.1 | 0.7 | 
| 11 | Media | 4.0 | 2.9 | 
| 12 | General Retailers | 3.8 | 3.5 | 
| 13 | Tobacco | 3.7 | 3.2 | 
| 14 | Health Care Equipment & Services | 3.4 | 0.9 | 
| 15 | Non-Life Insurance | 2.8 | 1.0 | 
| 16 | General Industrials | 2.4 | 2.0 | 
| 17 | Industrial Engineering | 2.2 | 0.7 | 
| 18 | Food & Drug Retailers | 1.9 | 7.9 | 
| 19 | Personal Goods | 1.7 | 0.5 | 
| 20 | Electronic & Electrical Equipment | 1.6 | 1.1 | 
| 21 | Electricity | 1.0 | 0.7 | 
| 22 | Technology Hardware & Equipment | 0.9 | 0.1 | 
| 23 | Real Estate Investment Trusts | 0.7 | 2.5 | 
| 24 | Real Estate Investment & Services | 0.3 | 0.6 |

Sources: BlackRock and Datastream.

**Investment size**

|  | Number of
investments | % of investmentsby market value | 
| < £1m | 32 | 39.9 | 
| £1m to £2m | 15 | 44.1 | 
| £2m to £3m | 3 | 16.0 |

Source: BlackRock.

**INVESTMENTS AS AT 30 APRIL 2021**

| 
  | Market value £’000  | % of investments  | 
| **Financial Services** |  |  | 
| 3i Group | 1,288  | 2.7  | 
| John Laing Group | 1,130  | 2.4  | 
| Premier Asset Management Group | 876  | 1.8  | 
| Mastercard^(1) | 828  | 1.8  | 
| Intermediate Capital Group | 620  | 1.3  | 
| IntegraFin | 486  | 1.0  | 
|  | —————–  | —————–  | 
|  | **5,228 ** | **11.0 ** | 
|  | ==========  | ==========  | 
| **Support Services** |  |  | 
| Ferguson | 1,316  | 2.8  | 
| Electrocomponents | 1,264  | 2.6  | 
| Grafton | 999  | 2.1  | 
| Hays | 864  | 1.8  | 
| Rentokil Initial | 656  | 1.4  | 
|  | —————–  | —————–  | 
|  | **5,099 ** | **10.7 ** | 
|  | ==========  | ==========  | 
| **Household Goods & Home Construction** |  |  | 
| Reckitt Benckiser | 2,194  | 4.6  | 
| Taylor Wimpey | 1,073  | 2.2  | 
| Berkeley Group | 607  | 1.3  | 
|  | —————–  | —————–  | 
|  | **3,874 ** | **8.1 ** | 
|  | ==========  | ==========  | 
| **Pharmaceuticals & Biotechnology** |  |  | 
| AstraZeneca | 2,927  | 6.1  | 
| Sanofi^(1) | 918  | 1.9  | 
|  | —————–  | —————–  | 
|  | **3,845 ** | **8.0 ** | 
|  | ==========  | ==========  | 
| **Mining** |  |  | 
| Rio Tinto | 2,540  | 5.3  | 
| BHP | 996  | 2.1  | 
|  | —————–  | —————–  | 
|  | **3,536 ** | **7.4 ** | 
|  | ==========  | ==========  | 
| **Oil & Gas Producers** |  |  | 
| Royal Dutch Shell ‘B’ | 1,710  | 3.6  | 
| BP Group | 1,176  | 2.5  | 
|  | —————–  | —————–  | 
|  | **2,886 ** | **6.1 ** | 
|  | ==========  | ==========  | 
| **Banks** |  |  | 
| Standard Chartered | 1,412  | 3.0  | 
| Lloyds Banking Group | 1,010  | 2.1  | 
|  | —————–  | —————–  | 
|  | **2,422 ** | **5.1 ** | 
|  | ==========  | ==========  | 
| **Life Insurance** |  |  | 
| Phoenix Group | 1,244  | 2.6  | 
| Legal & General Group | 952  | 2.0  | 
|  | —————–  | —————–  | 
|  | **2,196 ** | **4.6 ** | 
|  | ==========  | ==========  | 
| **Travel & Leisure** |  |  | 
| Whitbread | 889  | 1.9  | 
| Fuller Smith & Turner – A Shares | 580  | 1.2  | 
| Restaurant Group | 373  | 0.8  | 
| SSP | 289  | 0.6  | 
| Patisserie Holdings^(2) | –  | –  | 
|  | —————–  | —————–  | 
|  | **2,131 ** | **4.5 ** | 
|  | ==========  | ==========  | 
| **Food Producers** |  |  | 
| Unilever | 1,963  | 4.1  | 
|  | —————–  | —————–  | 
|  | **1,963 ** | **4.1 ** | 
|  | ==========  | ==========  | 
| **Media** |  |  | 
| RELX | 1,899  | 4.0  | 
|  | —————–  | —————–  | 
|  | **1,899 ** | **4.0 ** | 
|  | ==========  | ==========  | 
| **General Retailers** |  |  | 
| Moonpig Group | 751  | 1.6  | 
| Next | 657  | 1.4  | 
| WH Smith | 378  | 0.8  | 
|  | —————–  | —————–  | 
|  | **1,786 ** | **3.8 ** | 
|  | ==========  | ==========  | 
| **Tobacco** |  |  | 
| British American Tobacco | 1,773  | 3.7  | 
|  | —————–  | —————–  | 
|  | **1,773 ** | **3.7 ** | 
|  | ==========  | ==========  | 
| **Health Care Equipment & Services** |  |  | 
| Smith & Nephew | 1,607  | 3.4  | 
|  | —————–  | —————–  | 
|  | **1,607 ** | **3.4 ** | 
|  | ==========  | ==========  | 
| **Non-Life Insurance** |  |  | 
| Hiscox | 500  | 1.1  | 
| AXA^(1) | 470  | 1.0  | 
| Direct Line Group | 339  | 0.7  | 
|  | —————–  | —————–  | 
|  | **1,309 ** | **2.8 ** | 
|  | ==========  | ==========  | 
| **General Industrials** |  |  | 
| Smiths Group | 1,120  | 2.4  | 
|  | —————–  | —————–  | 
|  | **1,120 ** | **2.4 ** | 
|  | ==========  | ==========  | 
| **Industrial Engineering** |  |  | 
| Bodycote | 674  | 1.4  | 
| Chart Industries^(1) | 394  | 0.8  | 
|  | —————–  | —————–  | 
|  | **1,068 ** | **2.2 ** | 
|  | ==========  | ==========  | 
| **Food & Drug Retailers** |  |  | 
| Tesco | 908  | 1.9  | 
|  | —————–  | —————–  | 
|  | **908 ** | **1.9 ** | 
|  | ==========  | ==========  | 
| **Personal Goods** |  |  | 
| Burberry Group | 433  | 0.9  | 
| THG Holdings | 404  | 0.8  | 
|  | —————–  | —————–  | 
|  | **837 ** | **1.7 ** | 
|  | ==========  | ==========  | 
| **Electronic & Electrical Equipment** |  |  | 
| Oxford Instruments | 756  | 1.6  | 
|  | —————–  | —————–  | 
|  | **756 ** | **1.6 ** | 
|  | ==========  | ==========  | 
| **Electricity** |  |  | 
| Enel^(1) | 492  | 1.0  | 
|  | —————–  | —————–  | 
|  | **492 ** | **1.0 ** | 
|  | ==========  | ==========  | 
| **Technology Hardware & Equipment** |  |  | 
| Maxim Integrated^(1) | 427  | 0.9  | 
|  | —————–  | —————–  | 
|  | **427 ** | **0.9 ** | 
|  | ==========  | ==========  | 
| **Real Estate Investment Trusts** |  |  | 
| Big Yellow Group | 317  | 0.7  | 
|  | —————–  | —————–  | 
|  | **317 ** | **0.7 ** | 
|  | ==========  | ==========  | 
| **Real Estate Investment & Services** |  |  | 
| Hemnet Group^(1) | 119  | 0.3  | 
|  | —————–  | —————–  | 
|  | **119 ** | **0.3 ** | 
|  | ==========  | ==========  | 
| **Total investments** | **47,598 ** | **100.0 ** | 
|  | ==========  | ==========  |

^(1)    Non-UK listed investments.

^(2)    Company under liquidation.

All investments are in ordinary shares unless otherwise stated. The total number
of investments held at 30 April 2021 was 50 (31 October 2020: 48).

As at 30 April 2021, the Company did not hold any equity interests comprising more
than 3% of any company’s share capital.

**INTERIM MANAGEMENT REPORT AND RESPONSIBILITY STATEMENT**

The Chairman’s Statement and the Investment Manager’s Report above give details 
of the important events which have occurred during the period and their impact on
the financial statements.

**PRINCIPAL RISKS AND UNCERTAINTIES**
The principal risks faced by the Company can
be divided into various areas as follows:

·              Investment performance;
·              Income/dividend;·         
Gearing;·              Legal & regulatory compliance;·              Operational;·
Market; and·              Financial.

The Board reported on the principal risks and uncertainties faced by the Company
in the Annual Report and Financial Statements for the year ended 31 October 2020.
A detailed explanation can be found in the Strategic Report on pages 36 to 39 and
in note 16 on pages 91 to 97 of the Annual Report and Financial Statements which
are available on the website maintained by BlackRock at: www.blackrock.com/uk/brig.

An outbreak of an infectious respiratory illness caused by a novel coronavirus known
as COVID-19 has developed into a global pandemic. This coronavirus has resulted 
in travel restrictions, closed international borders, enhanced health screenings
at ports of entry and elsewhere, disruption of and delays in health care service
preparation and delivery, prolonged quarantines, cancellations, supply chain disruptions,
and lower consumer demand, as well as general concern and uncertainty. The impact
of COVID-19 has adversely affected the economies of many nations across the entire
global economy, individual issuers and capital markets, and could continue with 
extents that cannot necessarily be foreseen.

In addition, the impact of infectious illnesses in emerging market countries may
be greater due to generally less established health care systems. Public health 
crises caused by the COVID-19 outbreak may exacerbate other pre-existing political,
social and economic risks in certain countries or globally. The duration of the 
COVID-19 outbreak and its effects cannot be determined with certainty.

No investment objective is expected to be altered as a result of this event, and
the Investment Manager and Directors will continue to monitor the performance of
the Company on an ongoing basis.

In the view of the Board, other than those matters noted above, there have not been
any material changes to the fundamental nature of these risks since the previous
report and these principal risks and uncertainties, as summarised, are as applicable
to the remaining six months of the financial year as they were to the six months
under review.

**GOING CONCERN**
The Directors, having considered the nature and liquidity of the
portfolio, the Company’s investment objective and the Company’s projected income
and expenditure, are satisfied that the Company has adequate resources to continue
in operational existence for the foreseeable future and is financially sound. For
this reason, they continue to adopt the going concern basis in preparing the financial
statements. The Company has a portfolio of investments which are considered to be
readily realisable and is able to meet all of its liabilities from its assets and
income generated from these assets. Ongoing charges (calculated as a percentage 
of average daily net assets and using the management fee and all other operating
expenses, excluding finance costs, direct transaction costs, custody transaction
charges, VAT recovered, taxation and certain non-recurring items) for the year ended
31 October 2020 were approximately 1.19%.

**RELATED PARTY DISCLOSURE AND TRANSACTIONS WITH THE MANAGER**
BlackRock Fund Managers
Limited (BFM) was appointed as the Company’s Alternative Investment Fund Manager(
AIFM) with effect from 2 July 2014. BFM has, with the Company’s consent, delegated
certain portfolio and risk management services, and other ancillary services, to
BlackRock Investment Management (UK) Limited (BIM (UK)). Both BFM and BIM (UK) are
regarded as related parties under the Listing Rules. Details of the management fee
payable are set out in note 3 and note 11 below. The related party transactions 
with the Directors are set out in note 10 below.

**DIRECTORS’ RESPONSIBILITY STATEMENT**
The Disclosure Guidance and Transparency
Rules of the UK Listing Authority require the Directors to confirm their responsibilities
in relation to the preparation and publication of the Interim Management Report 
and Financial Statements.

The Directors confirm to the best of their knowledge that:

·        the condensed set of financial statements contained within the Half Yearly
Financial Report has been prepared in accordance with the applicable UK Accounting
Standard FRS 104 ‘Interim Financial Reporting’; and

·        the Interim Management Report, together with the Chairman’s Statement and
Investment Manager’s Report, include a fair review of the information required by
4.2.7R and 4.2.8R of the FCA’s Disclosure Guidance and Transparency Rules.

The Half Yearly Financial Report has not been audited or reviewed by the Company’s
Auditors.

The Half Yearly Financial Report was approved by the Board on 23 June 2021 and the
above responsibility statement was signed on its behalf by the Chairman.

**GRAEME PROUDFOOT**
**FOR AND ON BEHALF OF THE BOARD**23 June 2021

**For more information on the BlackRock Income and Growth Investment Trust and how
to access the opportunities presented by the income and growth sector, please visit:
[www.blackrock.com/uk/brig](https://www.blackrock.com/uk/individual/products/investment-trusts/our-range/blackrock-income-and-growth-investment-trust/trust-information?siteEntryPassthrough=true&cid=aff:investmenttrusts2020:brig:directorstalk:link)**

Share on:
